Extracellular ATP: a feasible target for cancer therapy
V Vultaggio-Poma, AC Sarti, F Di Virgilio - Cells, 2020 - mdpi.com
Adenosine triphosphate (ATP) is one of the main biochemical components of the tumor
microenvironment (TME), where it can promote tumor progression or tumor suppression …
microenvironment (TME), where it can promote tumor progression or tumor suppression …
Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis
R Nørregaard, HAM Mutsaers… - Physiological …, 2023 - journals.physiology.org
The kidneys play a key role in maintaining total body homeostasis. The complexity of this
task is reflected in the unique architecture of the organ. Ureteral obstruction greatly affects …
task is reflected in the unique architecture of the organ. Ureteral obstruction greatly affects …
Dynamic adjust of non‐radiative and radiative attenuation of AIE molecules reinforces NIR‐II imaging mediated photothermal therapy and immunotherapy
Due to the aggregation‐caused quenching effect and near‐infrared I poor penetration
capabilities of common fluorescent molecules, their applications in visualized imaging and …
capabilities of common fluorescent molecules, their applications in visualized imaging and …
Phenotypic diversity and metabolic specialization of renal endothelial cells
Complex multicellular life in mammals relies on functional cooperation of different organs for
the survival of the whole organism. The kidneys play a critical part in this process through …
the survival of the whole organism. The kidneys play a critical part in this process through …
[HTML][HTML] Coenzyme A fuels T cell anti-tumor immunity
Metabolic programming is intricately linked to the anti-tumor properties of T cells. To study
the metabolic pathways associated with increased anti-tumor T cell function, we utilized a …
the metabolic pathways associated with increased anti-tumor T cell function, we utilized a …
Biomimetic nanocarriers guide extracellular ATP homeostasis to remodel energy metabolism for activating innate and adaptive immunity system
L Wu, W Xie, Y Li, Q Ni, P Timashev, M Lyu… - Advanced …, 2022 - Wiley Online Library
Metabolic interventions via targeting intratumoral dysregulated metabolism pathways have
shown promise in reinvigorating antitumor immunity. However, approved small molecule …
shown promise in reinvigorating antitumor immunity. However, approved small molecule …
Blocking connexin 43 and its promotion of ATP release from renal tubular epithelial cells ameliorates renal fibrosis
H Xu, M Wang, Y Li, M Shi, Z Wang, C Cao… - Cell Death & …, 2022 - nature.com
Whether metabolites derived from injured renal tubular epithelial cells (TECs) participate in
renal fibrosis is poorly explored. After TEC injury, various metabolites are released and …
renal fibrosis is poorly explored. After TEC injury, various metabolites are released and …
Extracellular vesicles derived from CD73 modified human umbilical cord mesenchymal stem cells ameliorate inflammation after spinal cord injury
X Zhai, K Chen, H Yang, B Li, T Zhou, H Wang… - Journal of …, 2021 - Springer
Background Spinal cord injury (SCI) is an inflammatory condition, and excessive adenosine
triphosphate (ATP) is released into the extracellular space, which can be catabolized into …
triphosphate (ATP) is released into the extracellular space, which can be catabolized into …
History of ectonucleotidases and their role in purinergic signaling
H Zimmermann - Biochemical Pharmacology, 2021 - Elsevier
Ectonucleotidases are key for purinergic signaling. They control the duration of activity of
purinergic receptor agonists. At the same time, they produce hydrolysis products as …
purinergic receptor agonists. At the same time, they produce hydrolysis products as …
SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease
YP Lu, ZY Zhang, HW Wu, LJ Fang, B Hu… - Journal of Translational …, 2022 - Springer
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD)
worldwide. SGLT2 inhibitors are clinically effective in halting DKD progression. However, the …
worldwide. SGLT2 inhibitors are clinically effective in halting DKD progression. However, the …